By Editor , 2 October 2026
Smartee Launches Two Orthodontic Systems at First Overseas Summit

Palma de Mallorca, Spain – October 02, 2026 -- Smartee Denti-Technology concluded its first large-scale academic summit held outside China on September 19, drawing nearly 300 orthodontic clinicians from 27 countries to Palma de Mallorca and unveiling two new clear-aligner product systems for international markets.

By Editor , 2 October 2026
AKASA Launches Autonomous AI Coding Covering 10% of U.S. Discharges

South San Francisco, Calif. – October 02, 2026 -- AKASA has launched an autonomous AI platform for inpatient medical coding and clinical documentation integrity (CDI), expanding beyond its existing prebill review tools after inpatient volume processed by the company grew nearly 6x over the past year.

By Editor , 2 October 2026

Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

By Editor , 2 October 2026
Amen Clinics Study Finds Postpartum Depression Has Distinct Brain Patterns

Costa Mesa, Calif. – October 02, 2026 -- Nearly 40% of women with postpartum depression showed a hyperfrontal/anterior cingulate cortex brain-activity pattern, more than double the 19.4% rate found in patients with major depression, according to new research from Dr. Daniel Amen and colleagues at Amen Clinics.

By Editor , 2 October 2026
Angelalign Launches Pressure Points to Replace Torque Ridges in Europe

San Clemente, Calif. – October 01, 2026 -- Angelalign Technology Inc. (6699.HK) has launched Pressure Points in the European market, a feature that replaces its existing Torque Ridges and delivers a 25% increase in tooth surface contact in its single pressure point configuration.

By Editor , 2 October 2026
CooperVision Survey: Multifocal Lenses Rank Among Top Anti-Aging Picks

Rochester, N.Y. – October 01, 2026 -- Multifocal contact lenses ranked as the fourth most selected anti-aging product category among U.S. consumers aged 38 and older, tying with fitness memberships and aesthetic dental care and outranking cosmetic procedures, according to new CooperVision research.

By Editor , 2 October 2026
Lourdes Senior Community Closes $32.5M Bond Financing With Ziegler, WesBanco

Chicago – October 01, 2026 -- Ziegler, a specialty investment bank, has closed a $32,453,000 Series 2026 financing for Lourdes Senior Community, a single-site not-for-profit senior living provider in Waterford, Michigan.

Bond structure splits refunding and new construction debt

The financing comprises $14,453,000 in Series 2026A Refunding Revenue Bonds and $18,000,000 in Series 2026B Bank Draw Down Bonds. Proceeds will refinance Lourdes' outstanding Series 2019 Bonds and fund construction of a new 60-unit independent living building.

By Editor , 1 October 2026
CMS Grants NTAP Status to Cerapedics' PearlMatrix Bone Graft

Westminster, Colo. – October 01, 2026 -- The Centers for Medicare & Medicaid Services has granted New Technology Add-On Payment status to Cerapedics Inc.'s PearlMatrix P-15 Peptide Enhanced Bone Graft, enabling hospitals to recoup up to 65% of the additional cost tied to the device starting October 1, 2026.

By Editor , 1 October 2026
108 BioCapital Leads $4M Round in SedMed Toilet Lift Maker

Danbury, Conn. – October 01, 2026 -- 108 BioCapital is leading a $4 million investment in SedMed, Inc., a medical device maker whose non-electric toilet lift is already used across more than 40 hospital systems.

By Editor , 1 October 2026
CDC-Funded Report Finds 80% of U.S. Atopic Dermatitis Cases Undiagnosed

Novato, Calif. – October 01, 2026 -- Only about 6.9 million of the estimated tens of millions of Americans with atopic dermatitis (AD) had a documented diagnosis in 2023, roughly one in five of those believed to be affected, according to a new CDC-funded report from the National Eczema Association (NEA).